AdCare Wellness Systems third quarter 2013 revenues up 5 percent AdCare Wellness Systems, Inc http://www.sildenafilcitrate.net/ed-pills/ . , a leading long-term care provider, september 30 reported outcomes for the 3rd quarter and nine a few months ended, 2013. Financial Highlights Revenues up 5 percent to $55.9 million from $53.2 million in the year-ago period Adjusted EBITDAR from continuing functions was $5.4 million AdCare's financial results included a noncash derivative gain of $2.0 million compared to a noncash derivative lack of $2.68 per talk about on the Business's 10.875 percent Series A Cumulative Redeemable Preferred Stock which was paid on September 30, 2013 to holders of record at the close of business on September 20, 2013 Subsequent to the one fourth end, completed a public offering of 500,000 shares of its 10.875 percent Series A Cumulative Redeemable Preferred Share; $11.2 million net proceeds to be utilized for general corporate purposes; completed providing eliminates embedded derivative from monetary statements ‘The third quarter is usually our seasonally slowest quarter and yet we delivered solid income growth from the entire year ago period for both the third one fourth and the initial nine months of 2013,’ stated AdCare's president and chief executive officer, Boyd P.
There exists a clear dependence on alternative antiviral ways of treat influenza, specifically for immune-compromised sufferers at risk for development of drug resistance and severe clinical outcomes, said Menno de Jong, M.D., Ph.D., professor in Clinical Virology at the Division of Medical Microbiology, Academic Medical Center of the University of Amsterdam, and Chair of the Protocol Steering Committee because of this Stage 2 trial. Predicated on preclinical results showing that Adamas’ triple mix of amantadine, ribavirin, and oseltamivir is synergistic in its ability to block replication of the influenza virus, I believe Adamas’ strategy has much potential, and look forward to being involved with this scholarly study.